Atıf Formatları
Abdominal wall perforation in a patient with recurrent epithelial ovarian cancer after bevacizumab treatment
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

E. ALGIN Et Al. , "Abdominal wall perforation in a patient with recurrent epithelial ovarian cancer after bevacizumab treatment," Journal of Oncological Sciences , vol.2, no.2-3, pp.95-96, 2016

ALGIN, E. Et Al. 2016. Abdominal wall perforation in a patient with recurrent epithelial ovarian cancer after bevacizumab treatment. Journal of Oncological Sciences , vol.2, no.2-3 , 95-96.

ALGIN, E., GÜMÜŞAY, Ö., DOĞAN, M., & ÖZET, A., (2016). Abdominal wall perforation in a patient with recurrent epithelial ovarian cancer after bevacizumab treatment. Journal of Oncological Sciences , vol.2, no.2-3, 95-96.

ALGIN, EFNAN Et Al. "Abdominal wall perforation in a patient with recurrent epithelial ovarian cancer after bevacizumab treatment," Journal of Oncological Sciences , vol.2, no.2-3, 95-96, 2016

ALGIN, EFNAN Et Al. "Abdominal wall perforation in a patient with recurrent epithelial ovarian cancer after bevacizumab treatment." Journal of Oncological Sciences , vol.2, no.2-3, pp.95-96, 2016

ALGIN, E. Et Al. (2016) . "Abdominal wall perforation in a patient with recurrent epithelial ovarian cancer after bevacizumab treatment." Journal of Oncological Sciences , vol.2, no.2-3, pp.95-96.

@article{article, author={EFNAN ALGIN Et Al. }, title={Abdominal wall perforation in a patient with recurrent epithelial ovarian cancer after bevacizumab treatment}, journal={Journal of Oncological Sciences}, year=2016, pages={95-96} }